We are very pleased to announce that the abstract submission deadline for ICC 2023 has been extended to 11 June 2023.
Come and share your most recent work, research and experiences on CTEPH. We are keen to receive your abstracts!
Submitted research abstracts are considered for virtual poster presentation.
Accepted abstracts will be displayed on the conference programme published on the ICA website.
The Abstract Review Committee will nominate the best three submissions. These will be announced during the conference and published on ICA’s virtual channels. The winners will be presenting their abstracts as oral presentations.
The content of the abstract must be relevant to the field of Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
The author submitting the abstract must be a registered delegate at the conference.
All abstracts must be in line with the abstract submission guidelines.
Abstracts will be assessed by the Abstract Review Committee.
All abstracts submitted to ICC will be screened for relevance to the conference’s scientific content, and presentation. Abstracts not meeting the quality standards will not be accepted.
Abstracts submitted for consideration for oral presentation will be rated for scientific quality, novelty, and fit with the ICC’s scientific objectives.
Notification of outcomes of assessment for oral presentation and confirmation of acceptance of abstracts to the conference are expected to be available on 7 July 2023.